Nanotechnology for Targeted Therapy of Atherosclerosis is a research paper published in Frontiers in Pharmacology (2021). On theSindex it has a DataRank of 0. It has been cited 45 times.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
National Institute of General Medical Sciences
Grant: R01GM072667
National Institutes of Health
Grant: 3R01GM072667-11S1
Homogeneous Heparan Sulfate Glycopeptides: Synthetic and Functional Studies
Michigan State University
FWCI
2.42
Citation Percentile
0.9%
Citation Trend
Fields of Study
Keywords
Sustainable Development Goals